Literature DB >> 19077117

Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning.

Y S Mineur1, D H Brunzell, S R Grady, J M Lindstrom, J M McIntosh, M J Marks, S L King, M R Picciotto.   

Abstract

High-affinity, beta2-subunit-containing (beta2*) nicotinic acetylcholine receptors (nAChRs) are essential for nicotine reinforcement; however, these nAChRs are found on both gamma-aminobutyric acid (GABA) and dopaminergic (DA) neurons in the ventral tegmental area (VTA) and also on terminals of glutamatergic and cholinergic neurons projecting from the pedunculopontine tegmental area and the laterodorsal tegmental nucleus. Thus, systemic nicotine administration stimulates many different neuronal subtypes in various brain nuclei. To identify neurons in which nAChRs must be expressed to mediate effects of systemic nicotine, we investigated responses in mice with low-level, localized expression of beta2* nAChRs in the midbrain/VTA. Nicotine-induced GABA and DA release were partially rescued in striatal synaptosomes from transgenic mice compared with tissue from beta2 knockout mice. Nicotine-induced locomotor activation, but not place preference, was rescued in mice with low-level VTA expression, suggesting that low-level expression of beta2* nAChRs in DA neurons is not sufficient to support nicotine reward. In contrast to control mice, transgenic mice with low-level beta2* nAChR expression in the VTA showed no increase in overall levels of cyclic AMP response element-binding protein (CREB) but did show an increase in CREB phosphorylation in response to exposure to a nicotine-paired chamber. Thus, CREB activation in the absence of regulation of total CREB levels during place preference testing was not sufficient to support nicotine place preference in beta2 trangenic mice. This suggests that partial activation of high-affinity nAChRs in VTA might block the rewarding effects of nicotine, providing a potential mechanism for the ability of nicotinic partial agonists to aid in smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077117      PMCID: PMC2672109          DOI: 10.1111/j.1601-183X.2008.00468.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  37 in total

1.  GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.

Authors:  S R Laviolette; D van der Kooy
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

2.  125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.

Authors:  P Whiteaker; J M McIntosh; S Luo; A C Collins; M J Marks
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

3.  Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.

Authors:  L M Marubio; A M Gardier; S Durier; D David; R Klink; M M Arroyo-Jimenez; J M McIntosh; F Rossi; N Champtiaux; M Zoli; J-P Changeux
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

4.  Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.

Authors:  Huibert D Mansvelder; J Russel Keath; Daniel S McGehee
Journal:  Neuron       Date:  2002-03-14       Impact factor: 17.173

5.  Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.

Authors:  S R Grady; N M Meinerz; J Cao; A M Reynolds; M R Picciotto; J P Changeux; J M McIntosh; M J Marks; A C Collins
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

6.  In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice.

Authors:  Darlene H Brunzell; David S Russell; Marina R Picciotto
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

7.  Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior.

Authors:  Sarah L King; Michael J Marks; Sharon R Grady; Barbara J Caldarone; Andrei O Koren; Alexey G Mukhin; Allan C Collins; Marina R Picciotto
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

8.  Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat.

Authors:  J G P Ferreira; F Del-Fava; R H Hasue; S J Shammah-Lagnado
Journal:  Neuroscience       Date:  2008-02-15       Impact factor: 3.590

9.  Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.

Authors:  S R Laviolette; D van der Kooy
Journal:  Mol Psychiatry       Date:  2003-01       Impact factor: 15.992

10.  Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area.

Authors:  Steven R Laviolette; Tania O Alexson; Derek van der Kooy
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

View more
  20 in total

Review 1.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

2.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

3.  Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.

Authors:  Erin E Meyers; Esteban C Loetz; Michael J Marks
Journal:  Pharmacol Biochem Behav       Date:  2015-01-03       Impact factor: 3.533

4.  An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants.

Authors:  Christopher G Baddick; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2011-05-10       Impact factor: 5.858

5.  Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors.

Authors:  S M Anderson; D H Brunzell
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

6.  Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors.

Authors:  Miriam Melis; Stefano Carta; Liana Fattore; Stefania Tolu; Sevil Yasar; Steven R Goldberg; Walter Fratta; Uwe Maskos; Marco Pistis
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

Review 7.  Molecular mechanisms underlying behaviors related to nicotine addiction.

Authors:  Marina R Picciotto; Paul J Kenny
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 8.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

9.  Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice.

Authors:  Yan Rao; Yann S Mineur; Geliang Gan; Alex Hanxiang Wang; Zhong-Wu Liu; Xinyuan Wu; Shigetomo Suyama; Luis de Lecea; Tamas L Horvath; Marina R Picciotto; Xiao-Bing Gao
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

10.  Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.

Authors:  Darlene H Brunzell; Karen E Boschen; Elizabeth S Hendrick; Patrick M Beardsley; J Michael McIntosh
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.